Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 389

1.

The relationship between oxidative stress and nonalcoholic fatty liver disease: Its effects on the development of nonalcoholic steatohepatitis.

Ucar F, Sezer S, Erdogan S, Akyol S, Armutcu F, Akyol O.

Redox Rep. 2013;18(4):127-33. doi: 10.1179/1351000213Y.0000000050. Epub 2013 Jun 5. Review.

PMID:
23743495
2.

From fatty liver to fibrosis: a tale of "second hit".

Basaranoglu M, Basaranoglu G, Sentürk H.

World J Gastroenterol. 2013 Feb 28;19(8):1158-65. doi: 10.3748/wjg.v19.i8.1158. Review.

3.

Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities.

Gambino R, Musso G, Cassader M.

Antioxid Redox Signal. 2011 Sep 1;15(5):1325-65. doi: 10.1089/ars.2009.3058. Epub 2011 Apr 20. Review.

PMID:
20969475
4.

Role of ceramides in nonalcoholic fatty liver disease.

Pagadala M, Kasumov T, McCullough AJ, Zein NN, Kirwan JP.

Trends Endocrinol Metab. 2012 Aug;23(8):365-71. doi: 10.1016/j.tem.2012.04.005. Epub 2012 May 17.

5.

Review article: role of oxidative stress in the progression of non-alcoholic steatosis.

Albano E, Mottaran E, Occhino G, Reale E, Vidali M.

Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:71-3. Review.

6.

[Role of oxidative stress in non-alcoholic steatohepatitis].

Mitsuyoshi H, Itoh Y, Okanoue T.

Nihon Rinsho. 2006 Jun;64(6):1077-82. Review. Japanese.

PMID:
16768112
7.

Nonalcoholic fatty liver disease: current and potential therapies.

Ibrahim MA, Kelleni M, Geddawy A.

Life Sci. 2013 Feb 7;92(2):114-8. doi: 10.1016/j.lfs.2012.11.004. Epub 2012 Nov 15. Review.

PMID:
23159641
8.

Etiopathogenesis of nonalcoholic steatohepatitis.

Chitturi S, Farrell GC.

Semin Liver Dis. 2001;21(1):27-41. Review.

PMID:
11296694
9.

Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease.

Paradies G, Paradies V, Ruggiero FM, Petrosillo G.

World J Gastroenterol. 2014 Oct 21;20(39):14205-18. doi: 10.3748/wjg.v20.i39.14205. Review.

10.

The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation.

Chung HK, Kim YK, Park JH, Ryu MJ, Chang JY, Hwang JH, Lee CH, Kim SH, Kim HJ, Kweon GR, Kim KS, Shong M.

Liver Int. 2015 Apr;35(4):1341-53. doi: 10.1111/liv.12741. Epub 2015 Jan 10.

PMID:
25443620
11.

Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis.

Spahis S, Delvin E, Borys JM, Levy E.

Antioxid Redox Signal. 2017 Apr 1;26(10):519-541. doi: 10.1089/ars.2016.6776. Epub 2016 Aug 30. Review.

PMID:
27452109
12.

Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (NASH)?

Tariq Z, Green CJ, Hodson L.

Liver Int. 2014 Aug;34(7):e180-90. doi: 10.1111/liv.12523. Epub 2014 Mar 28. Review.

PMID:
24621397
13.

Iron overload in nonalcoholic steatohepatitis.

Fujita N, Takei Y.

Adv Clin Chem. 2011;55:105-32. Review.

PMID:
22126026
14.

[NASH -- nonalcoholic steatohepatitis].

Blechacz B, Stremmel W.

Z Gastroenterol. 2003 Jan;41(1):77-90. Review. German.

PMID:
12541180
15.

The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease.

Nomura K, Yamanouchi T.

J Nutr Biochem. 2012 Mar;23(3):203-8. doi: 10.1016/j.jnutbio.2011.09.006. Epub 2011 Nov 29. Review.

PMID:
22129639
16.

Pathophysiology of nonalcoholic steatohepatitis.

McCullough AJ.

J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S17-29. Review.

PMID:
16540762
17.

Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.

Carter-Kent C, Zein NN, Feldstein AE.

Am J Gastroenterol. 2008 Apr;103(4):1036-42. doi: 10.1111/j.1572-0241.2007.01709.x. Epub 2008 Jan 2. Review.

PMID:
18177455
18.

Nonalcoholic steatohepatitis and the metabolic syndrome.

Jiang J, Torok N.

Metab Syndr Relat Disord. 2008 Mar;6(1):1-7. doi: 10.1089/met.2007.0026. Review.

PMID:
18370830
19.

Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants.

Mehta K, Van Thiel DH, Shah N, Mobarhan S.

Nutr Rev. 2002 Sep;60(9):289-93. Review.

PMID:
12296456
20.

Markers in nonalcoholic steatohepatitis.

Armutcu F, Akyol S, Ucar F, Erdogan S, Akyol O.

Adv Clin Chem. 2013;61:67-125. Review.

PMID:
24015600

Supplemental Content

Support Center